Aberdeen Wealth Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,853
| Closed | -$210K | – | 168 |
|
|
2024
Q3 | $210K | Sell |
1,853
-2,265
| -55% | -$257K | 0.14% | 144 |
|
|
2024
Q2 | $510K | Sell |
4,118
-87
| -2% | -$10.8K | 0.34% | 84 |
|
|
2024
Q1 | $555K | Buy |
4,205
+2,273
| +118% | +$300K | 0.32% | 82 |
|
|
2023
Q4 | $211K | Sell |
1,932
-2,263
| -54% | -$247K | 0.15% | 140 |
|
|
2023
Q3 | $432K | Buy |
4,195
+4
| +0.1% | +$412 | 0.33% | 86 |
|
|
2023
Q2 | $484K | Buy |
4,191
+4
| +0.1% | +$462 | 0.35% | 79 |
|
|
2023
Q1 | $445K | Buy |
4,187
+5
| +0.1% | +$532 | 0.33% | 85 |
|
|
2022
Q4 | $464K | Buy |
4,182
+5
| +0.1% | +$555 | 0.35% | 79 |
|
|
2022
Q3 | $360K | Buy |
4,177
+4
| +0.1% | +$345 | 0.32% | 90 |
|
|
2022
Q2 | $380K | Buy |
4,173
+5
| +0.1% | +$455 | 0.3% | 90 |
|
|
2022
Q1 | $342K | Buy |
4,168
+6
| +0.1% | +$492 | 0.23% | 113 |
|
|
2021
Q4 | $319K | Sell |
4,162
-195
| -4% | -$14.9K | 0.21% | 116 |
|
|
2021
Q3 | $327K | Buy |
4,357
+5
| +0.1% | +$375 | 0.32% | 102 |
|
|
2021
Q2 | $338K | Buy |
4,352
+7
| +0.2% | +$544 | 0.31% | 103 |
|
|
2021
Q1 | $320K | Sell |
4,345
-466
| -10% | -$34.3K | 0.25% | 110 |
|
|
2020
Q4 | $376K | Buy |
4,811
+476
| +11% | +$37.2K | 0.28% | 96 |
|
|
2020
Q3 | $343K | Sell |
4,335
-1,394
| -24% | -$110K | 0.33% | 90 |
|
|
2020
Q2 | $423K | Buy |
5,729
+1,404
| +32% | +$104K | 0.45% | 74 |
|
|
2020
Q1 | $318K | Buy |
4,325
+4
| +0.1% | +$294 | 0.39% | 80 |
|
|
2019
Q4 | $375K | Buy |
+4,321
| New | +$375K | 0.28% | 95 |
|